Can lisinopril cause liver damage
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Liver Damage: An Overview
Introduction to Lisinopril and Hepatotoxicity
Lisinopril, an angiotensin-converting enzyme inhibitor (ACE-I), is widely used to manage hypertension and other cardiovascular conditions. While generally well-tolerated, there have been reports suggesting that lisinopril can cause liver damage in some patients. This article synthesizes findings from multiple studies to provide a comprehensive understanding of the potential hepatotoxic effects of lisinopril.
Case Reports of Lisinopril-Induced Liver Damage
Fulminant Hepatitis
One documented case involved a patient who developed fulminant hepatitis after taking lisinopril for five weeks. Symptoms included jaundice, fever, myalgia, and significantly elevated serum aminotransferase levels. Continued use of lisinopril led to severe complications, including grade III encephalopathy and a marked decrease in prothrombin and proaccelerin levels, indicating life-threatening hepatic failure .
Hepatocellular Disease
Another case described a 30-year-old woman who developed hepatocellular disease eight months after restarting lisinopril. She presented with fatigue and jaundice, and laboratory tests revealed elevated liver enzymes. Imaging suggested hepatocellular disease, and a liver biopsy confirmed moderate chronic inflammatory cell infiltrates. Discontinuation of lisinopril led to rapid clinical and biochemical improvement .
Cholestatic Liver Injury
A rare presentation of lisinopril-induced liver injury involved a 59-year-old woman who developed fulminant hepatic cholestasis. Despite discontinuing lisinopril, the patient's condition did not fully resolve, and she eventually succumbed to the illness. This case highlights the potential for severe, life-threatening liver damage from lisinopril .
Experimental Studies on Lisinopril and Liver Toxicity
Protective Effects Against Acetaminophen-Induced Hepatotoxicity
Interestingly, some studies have shown that lisinopril may have protective effects against certain types of liver damage. In a rat model, lisinopril was found to reduce serum transaminases and oxidative stress markers, suggesting a protective role against acetaminophen-induced hepatotoxicity .
Ischemia/Reperfusion Injury
Lisinopril has also been shown to mitigate ischemia/reperfusion (I/R) injury in the liver. In rat models, pre-treatment with lisinopril reduced levels of alanine aminotransferase (ALT), endothelin-1 (ET-1), and oxidative stress markers, indicating a protective effect on the liver during I/R injury 78.
Hepatocyte Degeneration
However, other studies have reported adverse effects. In a hypertension model induced by L-NAME, lisinopril treatment led to hepatocyte degeneration and elevated serum enzyme levels, suggesting potential hepatotoxicity under certain conditions .
Conclusion
While lisinopril is generally considered safe, there is evidence that it can cause significant liver damage in some patients. Case reports and experimental studies highlight both the potential hepatotoxic effects and protective roles of lisinopril, depending on the context. Clinicians should be aware of these risks and monitor liver function in patients taking lisinopril, especially if they present with symptoms of liver dysfunction. Further research is needed to fully understand the mechanisms behind lisinopril-induced liver injury and to identify patients who may be at higher risk.
Sources and full results
Most relevant research papers on this topic
Unique case of presumed lisinopril-induced hepatotoxicity.
Lisinopril-induced hepatotoxicity resolved after discontinuing the drug in a 30-year-old woman with no history of liver-related issues.
DOI